tweets by @protectmedicine

@ProtectMedicine

- 16 hours ago

#Biopharma is working to increase #diversity in all aspects of its research and development process. @BrighamWomens rose to the challenge and recruited over 30% of its enrollees in @moderna_tx's #COVID19 vaccine trials from communities of color. https://t.co/vXv8k8HBCP
@ProtectMedicine

- 1 day ago

Researchers at @NIAIDNews found that patients suffering from mild-to-severe #COVID19 symptoms were discharged 5 days sooner when treated with @GileadSciences#Remdesivir than those not treated, confirming the drug's effectiveness in treating the virus. https://t.co/Znt2IU4vDi
@ProtectMedicine

- 4 days ago

.@Regeneron is conducting clinical trials on its monoclonal antibody #COVID19 therapy. If the trials are successful & the therapy receives Emergency Use Authorization from the FDA, Regeneron will provide it for free to Americans suffering from COVID-19: https://t.co/ufzHYm2pMP
@ProtectMedicine

- 5 days ago

Wyoming lawmakers proposed importing Canadian prescription drugs to lower #drugprices. This would reduce #biopharma #innovation, increase the number of counterfeit drugs in the supply chain, & make long-term drug prices unsustainable. https://t.co/yhV2XVwYBk
@ProtectMedicine

- 7 days ago

.@RenovoRx’s new treatment RenovoCath nearly doubled the median survival rate of patients suffering from pancreatic cancer in its Phase 1 and Phase 2 clinical trials. Learn more: https://t.co/AdqpzpDcYc #innovation